Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

Vitetta, Luis; Sikali, Jason F; Fletcher, Courtney; Henson, Jeremy D

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Vitetta, Luis
dc.contributor.author	Sikali, Jason F
dc.contributor.author	Fletcher, Courtney
dc.contributor.author	Henson, Jeremy D
dc.date.accessioned	2022-08-24T04:48:57Z
dc.date.available	2022-08-24T04:48:57Z
dc.date.issued	2022	en
dc.identifier.uri	https://hdl.handle.net/2123/29457
dc.description.abstract	The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response rate (83%) among the 326 patients (13% of the total cohort) that had used a cannabis-based medicine. Notwithstanding the small sample size, it still constitutes an evaluable response rate, given that the use of cannabis for medicinal purposes in Denmark is permitted.	en
dc.language.iso	en	en
dc.publisher	Springer Nature	en
dc.relation.ispartof	Supportive Care in Cancer	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	Cannabis-based medicines	en
dc.subject	Smoked cannabis	en
dc.subject	Oral cannabis	en
dc.subject	Cannabinoids	en
dc.subject	Δ9-tetrahydrocannabinol (Δ9-THC)	en
dc.subject	Cannabidiol (CBD)	en
dc.title	Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.	en
dc.type	Article, Letter	en
dc.subject.asrc	0304 Medicinal and Biomolecular Chemistry	en
dc.identifier.doi	10.1007/s00520-022-06995-7
dc.type.pubtype	Author accepted manuscript	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::The University of Sydney School of Pharmacy	en
workflow.metadata.only	No	en